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Introduction 
The microenvironment of the hematopoietic system is
composed of stromal cells (Lord et al., 1975; Ogawa, 1993)
that interact and regulate the hierarchy of hematopoietic stem
cells (HSCs), progenitors, committed cells and functional
circulating blood cells (Lemischka, 1991; Metcalf, 1988).
Stromal cells within the context of the bone marrow (BM) and
liver are thought to maintain and support hematopoiesis
throughout adult and fetal stages, respectively (Jordan and
Lemischka, 1990; Moore and Metcalf, 1970). Indeed, many
BM and fetal liver stromal cell lines (Baum et al., 1992;
Breems et al., 1994; Collins and Dorshkind, 1987; Deryugina
et al., 1994; Lemoine et al., 1990; Moore et al., 1997a;
Wineman et al., 1996) have served as the basis of culture
systems for analyzing the growth, maintenance and
differentiation of hematopoietic cells and have been
demonstrated to be potent supporters of hematopoietic stem
and progenitor cells. Such cells elaborate a variety of
hematopoietic growth factors and have been used for
subtractive cDNA cloning approaches (Moore et al., 1997b;
Ohneda et al., 2000) to identify novel genes important in
stromal cell function. More recently, developmental studies
suggest that during early to midgestation, unique pre-fetal liver
microenvironments in the yolk sac and the aorta-gonads-
mesonephros (AGM) region also play an important role in the
differentiation, generation, maintenance and perhaps even the
expansion of the first hematopoietic cells in the mouse embryo
(Dzierzak et al., 1998; Godin et al., 1999; Medvinsky and
Dzierzak, 1996; Medvinsky et al., 1993; Müller et al., 1994).
However, only a limited number of immortalized stromal cell
lines from these embryonic hematopoietic microenvironements
have been isolated and characterized (Fennie et al., 1995;
Ohneda et al., 1998; Xu et al., 1998; Yoder et al., 1994; Yoder
et al., 1995). 
The generation of many of the stromal cell lines used
in hematopoietic studies has relied on the expression of the
SV40 Tag immortalizing gene (Jat and Sharp, 1986). The
conditionally active form (a thermolabile form that is active at
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Throughout life, the hematopoietic system requires a
supportive microenvironment that allows for the
maintenance and differentiation of hematopoietic stem
cells (HSC). To understand the cellular interactions and
molecules that provide these functions, investigators have
previously established stromal cell lines from the late
gestational stage and adult murine hematopoietic
microenvironments. However, the stromal cell
microenvironment that supports the emergence, expansion
and maintenance of HSCs during mid-gestational stages
has been largely unexplored. Since several tissues within
the mouse embryo are known to harbor HSCs (i.e. aorta-
gonads-mesonephros, yolk sac, liver), we generated
numerous stromal cell clones from these mid-gestational
sites. Owing to the limited cell numbers, isolations were
performed with tissues from transgenic embryos
containing the ts SV40 Tag gene (tsA58) under the
transcriptional control of constitutive and ubiquitously
expressing promoters. We report here that the growth and
cloning efficiency of embryonic cells (with the exception of
the aorta) is increased in the presence of the tsA58
transgene. Furthermore, our results show that the large
panel of stromal clones isolated from the different
embryonal subregions exhibit heterogeneity in their ability
to promote murine and human hematopoietic
differentiation. Despite our findings of heterogeneity in
hematopoietic growth factor gene expression profiles,
high-level expression of some factors may influence
hematopoietic differentiation. Interestingly, a few of these
stromal clones express a recently described chordin-like
protein, which is an inhibitor of bone morphogenic proteins
and is preferentially expressed in cells of the mesenchymal
lineage. 
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33°C) encoded by the tsA58 gene (Tegtmeyer, 1975) has been
routinely used to overcome the alteration of functional
or differentiation properties sometimes associated with
introduction of the SV40 Tag gene into the target cells. Most
often, the tsA58 gene has been introduced into cells via
retrovirus-mediated transduction (Jat et al., 1986), requiring
the cells of interest to divide ex vivo to achieve the integration
and expression of proviral sequences. Central to the use of cell
lines in the study of cellular differentiation and development is
the assumption that they are representative of cells that
function within the normal cellular physiology of the organism
(Ridley et al., 1988). Hence, to alleviate extensive cultivation
of target cells before the onset of immortalizing gene
expression, transgenic mice expressing the tsA58 gene have
been generated. 
The ‘Immortomouse’ (Jat et al., 1991), a transgenic mouse
strain expressing the tsA58 gene under the transcriptional
control of the H-2K promoter, has been used for the isolation
of cells from many different tissues including thymus (Jat et
al., 1991), colon and small intestine (Whitehead et al., 1993),
gonads (Capel et al., 1996), skeletal muscle (Morgan et al.,
1994) and smooth muscle (Ehler et al., 1995). To promote high
levels of of tsA58 expression, interferon-g is added during the
cultivation of transgenic cells. As interferons are general
activating agents and numerous investigators have
demonstrated the deleterious effects of interferon-g on
hematopoiesis (Gajewski et al., 1988; Klimpel et al., 1982;
Sato et al., 1995; Selleri et al., 1995; Selleri et al., 1996), the
addition of this cytokine may influence the outcome and
impose a bias on the cells isolated from the hematopoietic
microenvironment of the ‘Immortomouse’. Hence, other
transgenic mice using the SV40 transcriptional elements to
direct widespread expression of the temperature-sensitive Tag
gene (Yanai et al., 1991) have been generated. However, these
founder chimeric transgenic mice were not bred but were used
only to make primary cell lines and thus are not available for
the isolation of new cell lines. 
We were interested in more specifically and directly
isolating hematopoietic-supportive stromal cell lines from the
in vivo hematopoietic microenvironments present in the
midgestation embryo. This led us to generate our own
transgenic mouse lines, b -actin-tsA58 and PGK-tsA58, which
express the thermolabile form of the SV40 Tag gene in a
constitutive and ubiquitous manner. Here we present data on
the isolation of over a hundred stromal cell lines from
embryonic hematopoietic microenvironments. We show that
expression of the tsA58 transgene generally leads to the
more rapid and efficient isolation of hematopoietic stromal
cell populations and clones from embryonic tissues.
Furthermore, these stromal cell lines are effective but
heterogenous in human hematopoietic progenitor cell
support. For the individual stromal clones, the hematopoietic
gene expression profiles of growth factor and interleukin
genes are complex, showing no obvious pattern consistent
with support. However, a small subset shows high levels of
transcription of the chordin-like protein gene, the protein
of which is known to be a potent inhibitor of bone
morphogenic proteins. Taken together, we show that stromal
cells isolated from the various hematopoietic sites within
tsA58 transgenic mouse embryos can be effective supporters
of hematopoiesis. 
Materials and Methods 
Generation of plasmids for transgenesis
The NruI-BamHI human b -actin promoter fragment from plasmid
pBBgeopA (from Bill Scarnes, University of California, Berkeley)
was ligated with the tsA58 gene (purified by BglIand ScaI digestion,
blunting, and BamHI digestion of PucSV40/tsA58; gift of Parmjit Jat,
Ludwig Institute, London) to generate pHAtsA58. After BglII, BamHI
and ScaI digestion, the purified fragment was injected into mouse
oocytes. 
The HindIII-BglII fragment of the PGK promoter containing
plasmid pPGKneob (from Austin Smith, CGR, Edinburgh, UK) was
cloned into the EcoRV-BamHI fragment of SK–. This plasmid was
digested with ClaI followed by blunting and SalI digestion, and the
tsA58 gene (purified after BglI and ScaI digestion, blunting, and
BamHI digestion of PucSV40/tsA58) was cloned downstream of the
PGK promoter. The fragment of p(P+T+S) used for injection into
mouse oocytes was gel purified after digestion with BglII, BamHI and
ScaI. 
Mice
Mouse (CBA · C57BL/10)F1 oocytes were microinjected with 5
ng/ml of DNA, cultured overnight and implanted into
pseudopregnant females as previously described (Miles et al., 1997).
Founder mice and offspring were bred with (CBA · C57BL/10)F1
mice. Hence, the isolated stromal cell lines were on a
(CBA · C57BL/10)F1 outbred background. Animals were housed
according to institutional guidelines, and procedures were carried out
in compliance with the Standards for Humane Care and Use of
Laboratory Animals. 
Transgene and expression analysis
Transgenic mice were genotyped by PCR analysis of tail DNA. PCR
primer sequences are tsA58(S) 5¢ -tca acc tga ctt tgg agg ctt ctg-3¢ and
tsA58(AS) 5¢ - gtc aca cca cag aag taa ggt tcc-3¢ . PCR reactions were
performed at 1 cycle of 94°C for 4 minutes, 25 cycles of 94°C for 1
minute, 60°C for 2 minutes, 72°C for 2 minutes and 1 cycle of 72°C
for 10 minutes (resultant fragment is 277bp). 
RNA was isolated from adult transgenic tissues using lithium
chloride method (Fraser et al., 1990). cDNA was generated with
Superscript II reverse transcriptase (Gibco BRL/Life Technologies,
Breda, NL) and RT-PCR was performed using primers spanning the
SV40 large T antigen intron to yield a specific 372 bp fragment
(genomic DNA fragment is 720 bp). The primer sequences were:
SV40Tag(S) 5¢ gag ttt cat cct gat aaa gga gg 3¢ and SV40Tag(AS) 5¢
gtg gtg taa ata gca aag caa gc 3 ¢ . PCR reactions were performed at 1
cycle of 92°C for 5 minutes, 35 cycles of 92°C for 30 seconds, 60°C
for 45 seconds, 72°C for 1 minute and 1 cycle of 72°C for 10 minutes.
The GAPDH RT-PCR primers were gapdh-s 5¢ ctt cac cac cat gga gaa
gg 3¢ and gapdh-1 5¢ cca ccc tgt tgc tgt agc c 3 ¢ (product 670 bp).
Reactions were performed at 1 cycle of 92°C for 5 minutes, 30 cycles
of 92°C for 1 minute, 60°C for 2 minutes, 72°C for 2 minutes and 1
cycle of 72°C for 10 minutes. 
Isolation of stromal lines and clones
AGM, embryonic liver (EL) and gastrointestinal region (gut and
mesentery; GI) cells were obtained from Tag5 (8 E11), Tag11 (7 E11
and 12 E10) and control BL1b (35 E11) transgenic embryos (Dzierzak
and de Bruijn, 2002; Medvinsky and Dzierzak, 1996) (Fig. 1C). The
AGM region was subdissected using 27G needles into the aorta, with
surrounding mesenchymal tissue (AM), and the urogenital ridges,
containing the pro/mesonephros and the gonads (UG) (de Bruijn et
al., 2000a; de Bruijn et al., 2000b). Subdissected tissues from litters
with at least seven embryos were pooled and either explant cultured
at the air-medium interface on 0.1% gelatin-coated 6-well plates
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(Costar, Badhoevedorp, NL) or cultured as a single cell suspension
(after a 15 minute incubation with 0.25% trypsin and vigorous
pipetting) on 0.1% gelatin-coated 6-well plates in stromal medium:
50% long-term culture medium (M5300, StemCell Technologies,
Vancouver, BC, Canada), 15% FCS, 35% AlphaMEM, supplemented
with antibiotics (penicillin and streptomycin; Gibco), Glutamax-I
(Gibco) and 10 m M b -mercaptothanol (Merck Eurolab, Darmstadt,
Germany). After 4 to 5 days, supernatants were collected and adherent
tissues/cells harvested by brief 0.25% trypsin exposure and cultured
on new dishes at a density of 5 · 104 cells/cm2. Cultures were
supplemented with 10-20% 0.2 m m-filtered supernatant from the
previous passage each week until cell numbers increased consistently.
Cells were then cloned at a density of one cell per well in 0.1%
gelatin-coated 24-well plates. After 2-3 weeks clones were harvested
and expanded. 
Previously described stromal cell lines were used as controls for
various assays: AFT024 from K. Moore (Princeton U., USA) (Moore
et al., 1997a), S17 from Rudi Hendriks (Dept. of Immunology,
Erasmus U., Rotterdam, NL) (Collins and Dorshkind, 1987) and MS-
5 from Laure Coulombel (INSERM U474, Paris, France) (Itoh et al.,
1989). FBMD-1 cells were cultured as described previously (Breems
et al., 1994). 
Production of conditioned media
Stromal cells were grown to confluence in stromal medium. One day
after reaching confluence, the supernatant was collected. This
conditioned medium was further centrifuged for 7 minutes at 1,600 g
to remove the remaining cells and debris, filtered through 0.2 m m
filters (Schleicher and Schüll, Dassel, Germany) and stored at 4°C
until use.
Colony forming culture analysis
The number of murine colony-forming progenitors [colony forming
culture (CFC): total of erythroid burst-forming units (BFU-E),
granulocyte-erythroid-macrophage-megakaryocyte colony-forming
units (CFU-GEMM) and granulocyte-macrophage colony-forming
units (CFU-GM)] was determined by plating aliquots of BM cells in
methylcellulose medium supplemented with pokeweed mitogen-
stimulated spleen cell-conditioned medium (PWM-SCM) and human
erythropoietin (hu-EPO, 3 U/ml, M3430, StemCell Technologies). To
investigate the growth-stimulating properties of conditioned media,
BM cells were plated in methylcellulose medium with hu-EPO
(M3334, StemCell Technologies) additionally supplemented with
0.22 m m-filtered conditioned medium harvested from confluent
stromal cell cultures. Human CFC were assayed using 1.2%
methylcellulose in IMDM supplemented with 30% FCS, b -
mercaptoethanol (10–4 M), penicillin (100 U/ml), streptomycin (0.1
mg/ml), hu-EPO (1 U/ml), hu-IL3 (20 ng/ml), hu-GM-CSF (5 ng/ml),
hu-G-CSF (50 ng/ml) and mu-SCF (100 ng/ml). Duplicate cultures
were plated in 35 mm dishes (BD-Falcon) and incubated at 37°C, 10%
CO2 in a humidified atmosphere for 14 days. Colonies containing
more than 50 cells were scored at 10-12 days (murine CFC) or at day
14-18 (human CFC) by inverted light microscopy.
RT-PCR expression analysis
The following murine RT-PCR primer sets were used: TPO (S):
tgatggcagcacgaggacagttggaa; TPO (AS): gtgaggttccagcaaagagcccatg;
SCF (S): gattccagagtcagtgtcac; SCF (AS): ctggacacatgttcttgtcc; FL
(S): aaagaaaaactcgagatgacagtgctggcgccagcc; FL (AS): tttgactttttaatta-
attactgcctgggccgaggctctgg; G-CSF (S): gacggctcgccttgctctgcacca; G-
CSF (AS): acctggctgccactgtttctttagg; CHL-S (S): gtcatcaataacaagcac-
aaac; CHL-S (AS): ggagatagaggttagatagtag; CHL-L (S): gtggagaaga-
aaccatgcctg; CHL-L (AS): atgtgctctataaccacctgac; b -actin (S):
gtgggaattcgtcagaaggactcctatgtg; b -actin (AS): gaagtctagagcaacatagc-
acagc; IL-1b (S): cctgtgtaatgaaagacggc; IL-1b (AS): ggagattgagct-
gtctgctc; IL-3 (S): gatacccaccgtttaaccagaacgttg; IL-3 (AS): tcca-
cggttaggagagacggag; IL-6 (S): gacttcacagaggataccac; IL-6 (AS):
ctccagcttatctgttaggag; IL-11 (S): agatctggacagcgctgttctctcctaa; IL-11
(AS): agtcgagtctttaacaacagcaggcc; LIF (S): cgtggagtccagtgtcttgc; LIF
(AS): accgcttcttcctatcacac; OSM (S): gggtctgatgacacaagctg; OSM
(AS): acagagaacgctgacattcg; TGF-b 1 (S): cacagagaagaactgctgtg;
TGF-b 1 (AS): aggagcgcacaatcatgttgg. RNA made from confluent
layers of irradiated (30 Gy) stromal cell clones was used for the RT-
PCR analysis. 1 m g of total RNA (isolated by the Trizol method) per
reaction was used with a kit from Qiagen (Leusden, NL, OneStep RT-
PCR Kit cat# 210212). The conditions used for TPO RT-PCR were
50°C for 30 minutes, 95°C for 15 minutes followed by 33 cycles at
94°C for 30 seconds and 72°C for 70 seconds and a final step at 72°C
for 10 minutes (with Q buffer). For CHL-S and CHL-L RT-PCR, the
conditions were 50°C for 30 minutes, 95°C for 15 minutes followed
by 35 cycles at 94°C for 30 seconds, 60°C for 30 seconds and 72°C
for 40 seconds with a final step at 72°C for 10 minutes (with Q buffer).
For SCL, FLK-2L and G-CSF RT-PCR, the conditions were 50°C for
30 minutes, 95°C for 15 minutes followed by 33 cycles at 94°C for
30 seconds, 65°C for 30 seconds and 72°C for 40 seconds with a final
cycle at 72°C for 10 minutes (no Q-buffer). The conditions for IL-1,
-6 and -11 were 95°C for 5 minutes followed by 35 cycles at 95°C
for 1 minute, 56°C for 1 minute and 72°C for 2 minutes with a final
cycle at 72°C for 7 minutes; and for IL-3, OSM, LIF and TGF- b 1,
the conditions were 92°C for 5 minutes followed by 30 cycles at 92°C
for 45 seconds, 45°C for 58 seconds and 72°C for 1 minute with a
final cycle at 72°C for 7 minutes. 
Phenotypic surface analysis of stromal cells
Irradiated (30 Gy) stromal cells were surface phenotyped by FACS
analysis. Antibodies used for FACS analysis were anti-FL and SCF
(R&D Systems, Abingdon, UK) and anti-Flk-2/Flt-3 and IL-6R a and
Sca-1 (BD-Pharmingen, Heidelberg, Germany). Briefly, stromal cells
were irradiated (30 Gy) and grown for 2 weeks under LTC-CFC assay
conditions without cytokines. Cells were trypsinized, washed, stained
and analyzed on a FACScan (BD-Biosciences, Erembodegem,
Belgium). 
Extended long-term cultures of human cord blood cells on the
stromal clones
Human cord blood (CB) cells were obtained from term pregnancies
with informed consent. The cells were layered upon Ficoll-Paque
(density d=1.077 g/ml) and spun for 20 minutes at 600 g, and interface
cells were positively selected for the expression of CD34 using the
CD34 Isolation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany).
The purity of the CD34-selected CB cells was 90 – 3%. 
Stromal clones were grown to confluence in 25 cm2 flasks and
irradiated at 30 Gy with a 137Cs source. 1 or 2 · 104 CD34+ CB cells
were seeded and cultured in long-term culture (LTC) medium
(IMDM, 20% FCS, penicillin (100 U/ml), streptomycin (0.1 mg/ml),
b -mercaptoethanol (10–4 M, Merck), cholesterol (15 m M, Sigma,
Zwijndrecht, NL), linolic acid (15 m M Merck), iron-saturated human
transferrin (0.62 g/l, Intergen, Uithoorn, NL), nucleic acids (cytidine,
adenosine, uridine, guanosine, deoxyribonuclei 2 ¢ -deoxycytidine, 2 ¢ -
deoxyadenosine, thymidine, 2¢ -deoxyguanosine, all at 10–3 g/ml,
Sigma). Initially, cells were deposited on stromal layers without
cytokine supplements. However, since most stromal clones failed to
support extended long-term cultures, the cultures were further
supplemented by addition of thrombopoietin (TPO, 10 ng/ml,
Genentech, South San Fransisco, CA, USA). Flask cultures of each
group were set up in duplicate and maintained at 33°C and 10% CO2
for 12 weeks with weekly half medium changes and the consequent
removal of half of the non-adherent cells. At weeks 7/8 or 12 the total
cell cultures were assayed for the level of CFC. 
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Results 
Establishment of thermolabile SV40 T antigen
transgenic mice
Mice transgenic for the SV40 Tag immortalizing gene were
generated for the purpose of isolating cell lines, including
stromal cell lines, from embryonic hematopoietic tissues. The
transgenes consist of the temperature-sensitive form (tsA58) of
the SV40 Tag immortalizing gene under the control of the b -
actin or PGK (phosphoglycerate kinase) gene promoters,
which are known to direct the ubiquitous and stable expression
of transgenes in mice (Fig. 1A). Only four founder mice were
obtained after pronuclear injection of the tsA58 constructs into
a total number of 1670 eggs. Two founders (Tag5 and Tag16)
harbored the b -actin tsA58 construct. Both were healthy, but
only the Tag5 founder produced transgenic offspring. Of the
two founders harboring the PGK tsA58 construct (Tag 6 and
Tag11), both transmitted the transgene through the germline.
Although the Tag11 transgenic mouse line was healthy, the
Tag6 line had marked developmental abnormalities affecting
eye and bone structure. The Tag5 and Tag11 mice were
maintained as heterozygotes (homozygous transgenic males of
both strains were infertile) and used for all subsequent studies.
Both Tag5 and Tag11 mice contain one copy of the transgene
per genome as determined by Southern blot analysis (data not
shown). Expression analysis by RT-PCR revealed that both
lines transcribed the tsA58 transgene (Fig. 1B) in all tested
tissues. 
Establishment of stromal cell lines from tsA58 transgenic
mouse embryos
Embryos were generated from Tag5 and Tag11 transgenic lines
and also from a control transgenic strain of mice so that we
could evaluate the effects of the tsA58 gene in the isolation of
stromal cell lines. We used the BL1b transgenic line as the
control [(Miles et al., 1997); Ly-6E (Sca-1) lacZ transgene on
(C57BL/10 · CBA) outbred background], as Sca-1 is known to
be expressed on most stromal lines (Montecino-Rodriguez
et al., 1994). AGM regions, embryonic livers (EL),
gastrointestinal tracts (GI; gut and mesentery) and yolk sacs
were dissected at embryonic days 10 and 11 (E10 and E11)
(Fig. 1C). Previously, it has been suggested that at these times
during midgestation there may be differences in the HSC
generation and supportive capacities of the aorta and
surrounding mesenchyme when compared with the gonads and
mesonephros (de Bruijn et al., 2000b). Thus, AGMs were
subdissected into the aorta-mesenchyme (AM) and the gonad-
mesonephros (urogenital ridges, UG) (Fig. 1C) to examine
whether functional distinctions could be identified in stromal
cells isolated from these subregions.
Tissues were initially cultured at the air-medium interphase
at 33°C on gelatin-coated culture plates containing 250 m l of
stroma medium, as previously these conditions provided
efficient growth of HSCs in AGM explants (Medvinsky and
Dzierzak, 1996). Following one day of culture, adherent cells
were seen growing out of the explants. After 4 to 5 days of
culture, culture supernatants were harvested and the adherent
cells trypsinized and passaged at densities of 1-3 · 104/cm2
usually in the presence of 20% conditioned medium from the
previous passage. In this manner, more than 28 cultures were
established and grown for several months. At E11, the Tag11
line yielded one starting cell line per 1.4 embryos, and
the Tag5 line yielded one starting cell line per 1.6 embryos.
This is in contrast to the BL1b control transgenics, which
yielded one starting cell line for every three embryos. Thus,
the tsA58 transgene enhances the initial in vitro establishment
of cell populations from the midgestational hematopoietic
sites. 
Stromal cell line growth and cloning efficiency correlates
with the presence of the tsA58 transgene
The number of cells in the different cultures was monitored
at each passage so as to determine the effect of the tsA58
transgene on growth rates. Cells were passaged once a week
or earlier in cases when cells were more than 90% confluent.
As shown in Fig. 2, most cell populations, after the first 2 to
3 weeks of culture, regardless of whether the tsA58 transgene
was present or not, underwent a crisis in which the absolute
cell number decreased. This decrease persisted in the control
BL1b AM-derived cultures for approximately 6-8 weeks and
approximately 10 weeks in the BL1b UG-, EL- and GI-
derived cultures. Thereafter, cell numbers began to increase
and henceforth, all post-crisis cell populations are referred to
as stromal cell lines. Interestingly, increases in cell number
were observed earlier for all cell lines derived from tsA58
transgenic embryos and in particular from the EL (Fig. 2C).
(The increase occurred up to 8 weeks earlier in tsA58 EL than
in BL1b EL.) In contrast, the control BL1b AM-derived cells
increased their growth after 6 weeks, almost simultaneously
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Fig. 1. SV40 T antigen transgenic mice and stromal cell generation.
(A) The promoters for the constitutively and ubiquitously expressed
b -actin and PGK genes were cloned 5¢ to the temperature-sensitive
SV40 large T antigen (tsA58) gene. Transgenic mouse lines Tag5,
containing one copy of the b -actin tsA58 gene, and Tag11,
containing one copy of the PGK tsA58 gene, were used to generate
stromal cell lines and clones from embryonic tissues. (B) RT-PCR
analysis of RNA from adult Tag5 and Tag11 mice show expression
of the tsA58 transgene in all tissues tested. L, lymph nodes; K,
kidney; S, spleen; BM, bone marrow, B, brain; M, muscle. (C) The
embryonal subregions used for the isolation of stromal clones. E10
and E11 mouse embryos transgenic for the tsA58 gene or a lacZ
marker gene were used to generate stromal cell lines and clones from
dorsal aorta and mesenchyme (AM), urogenital ridges (UG,
mesonephros and genital ridges), the gastrointestinal region (GI) and
the liver (EL). Under our culture conditions, no cell lines could be
established from the yolk sac. Numbers in brackets indicate the
number of clones isolated from the various subregions. 
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with the increase in tsA58 AM cells, suggesting little or minor
affects by the immortalizing gene in this tissue (Fig. 2A).
Taken together, these data demonstrate that, with the
exception of the AM, the tsA58 transgene enhances the early
expansion of midgestational stage embryo-derived cell
populations. 
When the stromal cell lines showed a consistent increase
in absolute cell number for more than two passages, cloning
was performed at a density of one cell per well on gelatin-
coated plates in the presence of 30% conditioned medium
from the parental cell line. This corresponded to a time of 7
to 10 weeks after initiation of the cultures for the tsA58
transgenic tissues and between 9 to 14 weeks after initiation
of the BL1b-derived tissues. In this manner, we generated 32
AM-derived clones, 27 UG-derived clones, 18 EL-derived
clones, 4 GI-derived clones, as well as 12 clones from whole
AGM regions (Fig. 1C). Although a large number of clones
were derived from tsA58 cell lines, several were obtained
from the BL1b cell lines. The cloning efficiencies of cells
originating from each transgenic line are 3.5% for BL1b, 9%
for Tag5 and 13-15% for Tag11. These results demonstrate
that the tsA58 transgene not only increases the growth rate
but also the cloning efficiencies of stromal cells from the
midgestation embryo. 
Conditioned medium from stromal cell lines promotes
the differentiation and growth of hematopoietic colonies
Since the stromal cell lines were isolated from several
midgestational hematopoietic sites and each site is known to
harbor functionally different but some overlapping sets of
hematopoietic cells, it was of interest to first examine which
lines produced hematopoietic growth factors. Cell line
supernatants were harvested and tested for CFC-promoting
activity on adult BM cells in methylcellulose cultures. As
shown in Table 1, all the tested stromal cell lines from the AM,
UG and EL produced conditioned medium capable of
supporting the differentiated growth of CFCs. On average, the
AM-derived lines stimulated 48.2 CFC/104 BM cells (n=5),
UG-derived lines stimulated 49.8 CFC/104 BM cells (n=3) and
EL-derived lines stimulated 44.0 CFC/104 BM cells (n=5). No
correlation was observed between activity and tissue origin or
the presence of the tsA58 transgene. Also, the activity in the
supernatants of these stromal cell lines was similar to
supernatants isolated from other previously published stromal
clones: AFT024 [E14.5 EL-derived (Moore et al., 1997a)]
stimulated 35.8 CFC/104 BM cells, FBMD-1 [adult BM-
derived (Breems et al., 1994)] stimulated 37.5 CFC/104 BM
cells and S17 [adult BM-derived (Collins and Dorshkind,
1987)] stimulated 46.8 CFC/104 BM cells. 
In addition, conditioned media obtained from stromal clones
was measured using the CFC assay (Table 2). All tested
stromal clones produced conditioned medium with a similar
level of activity to the starting stromal lines. With the exception
of one AM-derived line and clone, none of the stromal lines or
clones surpassed the number of CFCs yielded by the PWM-
SCM control. The AM20 line and its derived clone AM20-1A4
consistently produced the highest numbers of CFCs (72.3 and
83.5 CFC/104 BM cells, respectively) and yielded 90.9-105.5%
and 114.0% activity (respectively) of the PWM-SCM control,
suggesting that these cells elaborate an abundance of
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Fig. 2. Growth rate analysis of cell lines established from
midgestation embryos. Cell lines were established from the (A)
aorta-mesenchyme, (B) urogenital ridges, (C) embryonic liver and
(D) gastrointestinal tissues of embryonic day 10 and 11 mice. The
number of cells in each culture was counted at each passage, and the
total number of viable cells (calculated) is plotted against time
(weeks in culture after initial plating). Black-filled symbols represent
cell lines derived from the tsA58 transgenic embryos, and white-
filled symbols represent cell lines derived from the control lacZ
transgenic embryos. All cell lines and clones established from Tag5
and Tag11 transgenic embryos contained the tsA58 transgene as
determined by PCR analysis. 
Table 1. Stimulation of CFC growth with stromal cell line
supernatants
CFC/104 BM Percentage of PWM 
Stromal line cells ± s.e.m. control ± s.e.m.
AM06† 32.3±5.7 40.6±7.2
AM10† 54.3±3.5 68.2±4.4
AM14† 33.0±6.4 41.5±8.1
AM20* 72.3±4.7 90.9±5.9
AM30 49.3±4.5 61.9±5.7
UG07† 55.0±4.6 69.2±5.8
UG15† 32.5±2.1 40.9±2.6
UG26 61.8±2.6 77.7±3.3
EL08† 61.0±5.1 76.7±6.4
EL12† 19.0±2.9 23.9±3.6
EL17*,† 48.3±2.8 60.7±3.5
EL23 47.5±2.7 59.7±3.4
EL28 44.3±4.6 55.7±5.8
AFT024 35.8±2.8 45.0±3.5
FBMD-1 37.5±2.8 47.2±3.5
S17 46.8±2.1 58.8±2.6
Four experiments were carried out. *Stromal lines derived from E10 tissue.
All other stromal lines are derived from E11 tissues. †Stromal lines derived
from BL1b transgenic embryos. All other stromal lines are derived from
tsA58 transgenic embryos. Culture supernatants were collected from non-
irradiated cells.
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hematopoietic growth factors. The AM20 and AM20-1A4
supernatants also promoted outgrowth of the different types of
CFC (BFU-E, GEMM-CFC and GM-CFC), comparable to
PWM-SCM (data not shown). In contrast to the other stromal
cells derived from E11 tissues, the AM20 line was derived
from an E10 AM subregion. Thus, despite the visible absence
of hematopoietic differentiation in vivo in the E10 and E11
AGM region, AGM-derived stromal cells are able to produce
conditioned medium that support the in vitro growth of BM-
derived CFCs. 
Stromal support for primitive progenitor cells in human
extended long-term co-cultures
To examine the ability of embryonic stromal clones to
support the sustained generation of primitive hematopoietic
progenitors, we tested the CFC production from human CD34+
cord blood cells co-cultured for 7 or 8 (7/8) and 12 days with
irradiated stromal clones. Pilot experiments demonstrated that
in the absence of growth factors, neither the clones nor FBMD-
1 or AFT024 control cells supported sustained CFC or
cobblestone-area-forming cell production (data not shown).
(N.K., R.A.J.O. and W. J. L. M. Koevoet et al., unpublished).
In the presence of TPO, several embryonic stromal clones
(AM06-2C4, AM20-1B4, UG15-1B7, UG26-2D3 and EL23-
1C2) still failed to support sustained progenitor production
(Table 3). However, UG26-1B4, UG26-3D4, AM30-2A4,
AM30-3A3 and AM30-3F4 maintained the number of
hematopoietic progenitors in the adherent compartment (an
expansion between half- and threefold). Several other clones
(AM30-1C6, UG26-1B6, GI09-2E6 and GI29-2B4) supported
a net expansion of CFC comparable to the control cells.
FBMD-1 and AFT024 showed a fourfold and twofold
expansion after 7/8 and 12 weeks, respectively. Interestingly,
EL08-1D2 supported a tremendous expansion of
hematopoietic progenitors in the adherent layer of more than
9- and 12-fold under similar conditions at weeks 7/8 and 12
after culture, respectively (Table 3). Thus, stromal clones from
several different murine embryonic sites support human
hematopoiesis.
Characterization of stromal clones for growth factor
mRNA expression
Since several of the embryonic stromal clones were capable of
supporting the in vitro hematopoietic differentiation of human
progenitors and the maintenance of murine stem cells
(Oostendorp et al., 2002), we tested and compared the relative
levels of expression of growth factors thought to be important
in hematopoiesis using RT-PCR. We also measured the
expression of the recently described chordin-like protein
(CHL) in the short and long forms (-S and -L), which
are inhibitors of bone morphogenetic proteins and are
preferentially expressed in mesenchymal cells (Nakayama et
al., 2001). 
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Table 2. Stimulation of CFC growth with stromal clone
supernatants
CFC/104 BM Percentage of PWM 
Stromal clones ± s.e.m. control ± s.e.m.
AM14.1C4† 52.8±1.9 72.0±2.6
AM20.1A4* 83.5±4.5 114.0±6.1
AM30.1C6 40.5±3.5 55.3±4.8
AM30.2A4 52.5±1.5 71.7±2.0
AM30.2B4 43.5±1.5 59.4±2.0
AM30.3A3 48.5±5.5 66.2±7.5
AM30.3E8 39.5±9.5 53.9±13.0
AM30.3F4 46.0±1.0 62.8±1.4
UG15.1B7† 47.0±1.0 64.2±1.4
EL23.1C5 39.5±8.0 53.9±10.9
EL23.1C6 21.5±2.5 29.4±3.4
EL23.2A2 50.3±4.1 68.6±5.6
EL23.2D3 46.5±0.5 63.5±0.7
EL28.1B3 56.5±11.0 77.1±15.0
EL28.1D3 46.5±0.5 63.5±0.7
EL28.2B2 39.0±4.0 53.2±5.5
AM20 77.3±4.2 105.5±5.7
These are the results of between two and four experiments. *Stromal clones
derived from E10 tissue. All other stromal clones derived from E11 tissues.
†Stromal clones derived from BL1b transgenic embryos. All other stromal
clones are derived from tsA58 transgenic embryos. Culture supernatants were
collected from non-irradiated cells. 
Table 3. Long-term support of human adherent CFC
production 
Fold increase in input CFCs
7/8 week culture 12 week culture
Stromal cells TPO TPO + FL TPO TPO + FL
FBMD-1 3.7 3.8 1.4 2.4
AFT024 4.8 5.2 2.4 3.4
AM06-1C4 0.1 0.6 nd nd
AM06-2C4 0.3 0.7 0.0 0.0
AM20-1A4 2.9 1.3 nd nd
AM20-1B4 0.0 0.0 0.0 0.0
AM30-1C6 3.6 2.5 0.9 0.5
AM30-2A4 1.9 0.3 0.3 0.3
AM30-3A3 0.9 0.1 0.4 0.3
AM30-3F4 1.9 2.3 0.6 0.9
AM30-3F5 0.9 0.0 nd 1.1
UG07-1C6* 0.6 2.7 nd nd
UG15-1B7* 0.0 0.0 0.0 0.0
UG26-1B4 1.3 3.3 0.5 0.3
UG26-1B6 2.2 5.0 1.1 2.3
UG26-2D3 0.1 nd 0.0 0.0
UG26-3D4 1.5 nd 0.3 1.3
EL08-1D2* 9.1 11.8 11.4 12.6
EL23-1C2 0.9 0.5 0.0 nd
GI09-2E6* 1.8 1.3 0.9 0.8
GI29-2B4 2.3 4.2 1.1 2.3
Human cord-blood-derived CD34+ cells were cultured on irradiated
embryonic stromal cells in the presence of TPO or a combination of TPO and
FL. Data represent the CFC content of the adherent layers in the extended
LTC as measured on weeks 7/8 and 12 as the fold increase in the input
population of cells. The input, uncultured material contained 1.8 – 1.0· 104
CFC per 105 CD34+ human CB cells. LTC were maintained by weekly
change of the half medium with removal of half of the non-adherent cells in
the presence of added TPO (10 ng/ml) or a combination of TPO and Flt3-
ligand (FL, 50 ng/ml). At the designated culture time, the adherent layers
were washed twice with serum-free medium and trypsinized. AM, aorta-
mesenchyme; UG, urogenital ridges; GI, gastrointestinal tract; EL, embryonic
liver. *Stromal clones derived from BL1b transgenic embryos. All other
stromal clones were derived from tsA58 transgenic embryos. The lines UG26-
1B6, GI29-2B4 and EL08-1D2 score similarly overall or even better than the
control cell lines FBMD-1 and AFT024. Data represent the mean of one to
three independent experiments each containing four cultures per group. nd,
not determined.
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In the first experiments, mRNA isolated from 22 stromal
(non-irradiated) clones was analysed for the expression of
thrombopoietin (TPO), stem cell factor (SCF), Flk-2 ligand
(FL), granulocyte-colony stimulating factor (G-CSF) and
CHL-S and -L genes in a semi-quantitative manner. As shown
in Table 4, most of the stromal clones expressed TPO, SCF and
G-CSF mRNA to varying levels. TPO and SCF were expressed
from high to intermediate levels in 14/22 and 17/22 of the
clones, respectively. G-CSF was expressed predominantly at
intermediate levels (12/22 of the clones). In contrast, the Flk-
2 ligand was expressed only at a low level in 14/22 of the
clones. For comparison, in adult marrow-derived stromal cell
lines (FBMD-1, M2-10B4, and MS-5), the expression of TPO,
SCF, G-CSF and FL was high. But, all in all, no overall
consistent pattern of expression was observed for this panel of
molecules within the stromal clones tested. However, a
restricted high-level expression (both forms) of the CHL gene
was observed in 4/22 of the stromal clones tested. A further
three clones expressed CHL to intermediate levels and 13
clones expressed no CHL-S and only low level or no
expression of CHL-L. The expression patterns do not correlate
with derivation from a specific embryonic day, tissue or
transgenic line. The three marrow-derived lines all expressed
the long form of CHL, but the short form was only observed
in FBMD-1.
Additionally, we examined 15 embryonic stromal clones for
their expression of growth factors IL-1, -3, -6, -11, LIF,
Oncostatin M and TGF-b 1 by RT-PCR after irradiation (since
the clones were irradiated in the hematopoietic support
experiments). As shown in Table 4, varying expression patterns
were observed. Consistently, we found that the stromal clones
did not express detectable levels of IL-3 and Oncostatin M
(OSM) transcripts, even though cDNA controls (WEHI 3 for
IL-3 and fetal liver for OSM) were strongly positive. IL-1, IL-
11 and LIF expression was found in only a few of the clones,
whereas most of the stromal clones expressed IL-6 and TGF-
b 1. Taken together with CFC data, no correlation can be found
between expression patterns and supernatants promoting
hematopoietic growth. Thus, the clones tested exhibit a
heterogeneous pattern of growth factor expression on the
mRNA level. 
Surface phenotype of stromal cells
FACS analysis was performed on a small number of irradiated
stromal clones (chosen for their ability to support sustained
CFC production) and the control, FBMD-1, to determine
whether some growth factors and growth factor receptor
proteins were produced and elaborated on the cell surface. As
in the co-cultures, the lines were irradiated and grown in LTC
medium. FACS analysis revealed SCF expression at low levels
on the surface of one of the clones, AM20-1B4 (Table 5). Only
GI29-2B4 was found to express the FL. None of the clones
expressed the Flk-2 receptor tyrosine kinase. However, IL-6Ra
expression was found on six out of six of the tested clones.
In addition, all of the lines, including FBMD-1, strongly
Table 4. Hematopoietic growth factor semi-quantitative RT-PCR expression analysis of embryonic and control stromal
clones
TPO SCF FL G-CSF CHL-S CHL-L IL-1 b IL-3 IL-6 IL-11 LIF OSM TGF- b 1
516† 586 603 515 979 750 330 400 420 485 520 350 295 b -actin
FBMD-1 2 4 3 4 2 3 0 0 1 1 1 0 2 3
M2-10B4 2 3 3 3 0 2 nd nd nd nd nd nd nd 3
MS-5 3 4 3 4 0 2 nd nd nd nd nd nd nd 3
AM14-1C4* 2 3 2 3 3 3 2 0 2 2 0 0 3 3
AM20-6B4 0 1 1 0 0 1 nd nd nd nd nd nd nd 3
AM20-3C3 0 3 2 2 0 1 nd nd nd nd nd nd nd 3
AM30-1C6 3 2 1 1 0 1 nd nd nd nd nd nd nd 3
AM30-2A4 0 3 1 1 0 1 1 0 2 0 0 0 1 3
AM30-3A3 2 1 1 1 0 1 2 0 2 0 1 0 0 3
AM30-3E8 2 1 0 0 0 1 1 0 0 0 0 0 0 3
AM30-3F4 2 3 2 2 2 2 1 0 1 2 0 0 3 3
AM30-3F5 3 2 0 2 0 0 0 0 1 1 0 0 0 3
UG07-1C6* 3 1 1 1 0 0 nd nd nd nd nd nd nd 3
UG15-1B7* 0 1 0 0 0 0 nd nd nd nd nd nd nd 1
UG26-1B4 0 2 1 1 2 2 nd 0 nd nd 1 0 2 3
UG26-1B6 2 3 1 2 2 2 2 0 3 0 1 0 3 3
UG26-2B3 2 2 1 2 0 0 nd 0 nd nd 2 0 3 3
UG26.3B5 nd nd nd nd nd nd 0 0 2 1 2 0 3 nd
UG26-2D3 3 3 1 2 3 3 1 0 3 2 0 0 1 3
UG26-3D4 1 3 1 2 0 1 2 0 3 1 1 0 2 3
EL08-1D2* 3 3 3 2 3 3 0 0 2 0 0 0 1 3
EL08-2C2* 1 2 1 2 1 1 1 0 0 0 0 0 0 3
EL23-1B4 2 3 2 2 1 1 nd nd nd nd nd nd nd 3
EL28-1B3 2 2 1 2 0 1 nd nd nd nd nd nd nd 3
GI09-2E6* 2 2 1 2 3 3 1 0 1 1 2 0 3 3
GI29-2B4 1 2 1 1 0 0 0 0 2 1 3 0 3 3
*Stromal clones derived from BL1b transgenic embryos. All other stromal clones are derived from tsA58 transgenic embryos. †Fragment size of RT-PCR
product. Signal intensity: 4, extremely high; 3, high; 2, intermediate; 1, low; 0, no expression; nd, not determined. RNA was prepared from non-irradiated stromal
cells, and normalization with b -actin signal was performed for TPO, SCF, FL, G-CSF, CHL-S and -L RT-PCRs. RNAs for the remaining RT-PCRs were from
irradiated stromal clones, and the GAPDH signal (not shown) was used for normalization. Signal intensities were compared only within a PCR set and not
between PCR sets.
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expressed the Sca-1 antigen, a marker expressed on all
supportive stromal cell lines (Rémy-Martin et al., 1999). Taken
together, these limited protein expression data do not correlate
with site of origin of the stromal clone or the presence of the
tsA58 transgene and support the notion that the isolated stromal
clones are heterogeneous.
Discussion 
We have shown here that it is possible to isolate a large panel
of hematopoietic stromal clones from the earliest stages of
HSC appearance in E10 and E11 mouse embryos and in
particular from distinct ontogenic sites. Owing to the limited
number of cells available from these subdissected embryonic
tissues and the low frequency of spontaneous cell
immortalization in culture, we used the SV40 tsA58
immortalizing gene to aid in stromal cell isolation. The SV40
Tag gene has been used as an immortalizing agent for many
years. Its immortalizing activity is based upon its interaction
with the retinoblastoma protein and p53, and their regulators
p21CIP1/WAF1 and p16INK4, and the recently described tumor
suppressor gene SEN6 leading to extended proliferation (Smith
and Pereira-Smith, 1996). Rather than using the commercially
available ‘Immorto’ mouse (Jat et al., 1991) or the transient
transgenic approach (Okuyama et al., 1995a; Okuyama et al.,
1995b), we generated two new mouse lines, Tag5 and Tag11,
that express the tsA58 gene under the control of the b -actin or
PGK gene promoters. 
In the numerous fertilized mouse eggs microinjected with
b -actin- and PGK-tsA58 constructs, we found a low
frequency of transgenesis. Although it is clear that construct
preparation, the quality of the eggs and the injection
procedure play an important role in the success of
transgenesis, we were able to produce only four transgenic
founders. One founder did not pass the transgene through the
germline, and one had severe eye and skeletal problems.
Thus, the tsA58 protein may have some debilitating effects in
vivo both at developmental and adult stages. It is possible that
areas of lower temperature (i.e. testis, long bones) could
promote activation of the T antigen protein and result in
abnormal cell function. Additionally, alterations in
expression levels caused by the site of transgene integration
and/or the specific sites of T antigen protein production may
play a role in such abnormalities. The result that only low
copy numbers were found in the two established transgenic
lines, together with the low efficiency of transgenic founder
generation, strongly suggests that high copy number/high
expression levels are prohibitive for viability. 
The presence of the tsA58 gene leads to more efficient
stromal cell line and clone isolation from embryonic
tissues, except for the aorta-mesenchyme
We have demonstrated that the use of b -actin and PGK-tsA58
transgenic mice was instrumental in the efficient isolation of
so many lines from early midgestation embryos. By direct
comparison, twice as many lines were isolated from the tsA58
transgenic embryos than from the control lacZ transgenic
embryos. Furthermore, the presence of the tsA58 gene allowed
for a three- to four-fold greater cloning efficiency compared
with control lacZ marker transgenics. Although the limiting
dilution culture step assured us that our stromal cells were
clonal (yielding morphologically divergent clones as compared
with the initial lines), in some cases the initial lines may
already have been clonal.
Although the tsA58 gene had an enhancing effect on the
growth of EL-, UG- and GI-derived cell lines, it did not affect
the growth of AM-derived lines. What is most intriguing is that
this subregion undergoes such a short crisis phase, followed by
rapid growth. The cells from the AM may be already
undergoing such a high rate of proliferation that their growth
could not be further increased by tsA58. Our preliminary data
with in vivo BrdU labeling of embryos suggests that the cells of
the AM are undergoing rapid proliferation (E.D., unpublished).
Thus, with an interest in understanding the generation and
expansion of the hematopoietic system in the AGM region, the
molecular basis of the high proliferation rate of AM-derived
cells will be further examined. 
Most embryonic stromal cell lines and clones express
hematopoietic growth factors
By analyzing the supernatants of the stromal cell lines, we were
able to determine that all the isolated cell lines and clones do
have hematopoiesis-promoting activity, with the E10 AM-
derived line AM20 producing the most effective conditioned
medium. RNA and/or FACS analysis revealed that most of the
stromal clones tested expressed a panel of hematopoietic
growth factors. All of our clones were positive for SCF
transcripts. However, FACS analysis showed detectable SCF
protein on only one out of the six clones tested, suggesting that
the majority of clones secrete SCF, which is known to be
important for the migration, proliferation and/or differentiation
of early hematopoietic progenitors. And although most of the
clones expressed TPO RNA, we found no surface-bound TPO
(data not shown), suggesting that a secreted form may provide
support for HSCs, which are known to express c-mpl, the
receptor for TPO (McKinstry et al., 1997). Future studies will
test for support of HSCs by our stromal clones in non-contact
cultures. Similar to the previously published AGM stromal
clones (Ohneda et al., 1998; Xu et al., 1998), our clones
exhibited variable expression of IL-11 and LIF, low expression
of IL-1 and no expression of IL-3 and OSM. Contrasting with
the three published AGM stromal clones (Ohneda et al., 1998;
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Table 5. Surface molecule expression on stromal clones
Clone SCF FL Flk-2 IL-6Ra Sca-1
FBMD-1 - - - nd +
AM06.1C4* - - - + +
AM20.1B4 +/- - - + +
UG15.1B7* - - - + +
UG26.1B6 - - - + +
EL08.1D2* - - - + +
GI29.2B4 - +/- - + +
Irradiated stromal cells were immunostained and analyzed using a FACS
scan. Cells considered positive (+) contained greater than 10% of cells
expressing these antigens. +/– indicates that between 1 and 5% of the cells
expressed the antigen. Negative (–) indicates that no or less than 1% of cells
expressed the antigen. Analysis was performed at least three times on
irradiated cells. *Stromal clones were derived from BL1b transgenic
embryos. All other stromal clones are derived from tsA58 transgenic embryos.
nd, not determined.
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Xu et al., 1998), most of our stromal clones were positive for
G-CSF RNA. Finally, the expression patterns of TGF- b 1 and
CHL in our stromal clones are the most intriguing. TGF- b 1
was thought to have a strong negative influence on the growth
of HSCs. Surprisingly, we found high levels of TGF- b 1
expression in most of our stromal clones, even in the supportive
clones. However, in some of the clones we also found
expression of the CHL gene (both forms). The CHL protein is
thought to inhibit the negative effects of BMP-4 and TGF b
molecules on hematopoietic cells (Nakayama et al., 2001).
Hence, the appropriate balanced expression of these molecules
in the stromal clones may be important for hematopoietic-
supportive properties, and future experiments should examine
such interactions. 
Stromal clones supporting human hematopoietic
progenitors express most hematopoietic growth factors
In functional studies examining the long-term support of
human hematopoietic progenitors, we found a few stromal
clones from each of the embryonic hematopoietic subregions
to be highly active: AM-derived AM30-1C6 and AM30-3F4,
urogenital-ridge-derived UG26-1B4 and UG26-1B6,
gastrointestine-derived GI09-2E6 and GI29-2B4 and the
embryonic liver-derived EL-08-1D2, which is the best,
supporting three- to five-fold expansion of CFC production in
12 week cultures supplemented with FL and/or TPO (Table 3).
In related studies characterizing the stromal cell support for
murine progenitors and HSCs (Oostendorp et al., 2002), we
found that most of these clones also support the long-term
maintenance of adult BM-enriched murine HSCs and that the
second best supporter of human CFC production, UG26-1B6,
is best at maintaining murine HSC activity (Oostendorp et al.,
2002). Interestingly, five out of the seven clones listed above
express both forms of the CHL gene. Thus, when compared
against the expression profiles, there appears to be a correlation
between widespread, high-level growth factor/CHL
transcription and long-term support for human and mouse
hematopoietic progenitors. 
In conclusion, the Tag5 and Tag11 transgenic lines of mice
have been instrumental in the isolation of numerous
hematopoietic stromal cells to further our studies of the
midgestational hematopoietic microenvironment. We have
shown here that these each of the subregions yields
hematopoietic supportive stromal clones and that they
transcribe an abundance of hematopoietic growth factors. A
general trend in expression profiles suggests that widespread,
high level transcription of at least some of these factors is
necessary for hematopoietic support. In future studies these
stromal clones will serve as the basis for comparative
microarray screening to further evaluate the complex panel of
genes necessary for the growth and maintenance of
hematopoietic progenitors. 
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